HRS 2020: Medtronic’s Pacemaker Monitoring App Proves Reliable In BlueSync Study
The BlueSync Evaluation study showed pacemaker patients using the MyCareLink Heart mobile device app were able to stick to their prescribed transmission schedule more often than patients using beside consoles.
You may also be interested in...
Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.